STI Testing and Rates of STI Diagnoses Before and During the COVID-19 Pandemic in a US HIV Cohort
The fallout of the COVID-19 pandemic on sexual health may not be seen for some time. Despite reduced STI testing, rates of STI diagnoses did not decrease. It will take a return to more routine screening and improved access to sexual health care to uncover the true impact of undetected or untreated STIs.
Authors
- Cynthia Firnhaber (ORCID: https://orcid.org/0000-0002-7748-9321)
- Kate Buchacz (ORCID: https://orcid.org/0000-0001-5335-5217)
- Cynthia Mayer
- Carl Armon (ORCID: https://orcid.org/0000-0003-3789-4485)
- Gina Simoncini (ORCID: https://orcid.org/0000-0001-8212-7563)
- Alexander C. Ewing (ORCID: https://orcid.org/0000-0002-9950-8095)
- Kimberly Carlson (ORCID: https://orcid.org/0000-0003-2022-8750)
- Marcus D. Durham (ORCID: https://orcid.org/0000-0002-3552-1100)
- Jun Li (ORCID: https://orcid.org/0000-0002-8664-4813)
- Qingjiang Hou
- Jack Fuhrer
- Jonathan D. Mahnken
- Kalliope Chagaris
Institutions
- Centers for Disease Control and Prevention (US)
- Cerner (United States) (US)
- Denver Public Health (US)
- Stony Brook Medicine (US)
- St. Joseph's Hospital (US)
- Institute for Conflict Research (GB)
- University of Colorado Anschutz Medical Campus (US)
- Philadelphia University (US)
Publication Details
- Journal
- Sexually Transmitted Diseases
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1097/olq.0000000000002124
- Citations
- 1
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 1.18